Sign in
4

Changes in Ownership

Spero Therapeutics, Inc. Filed Acc 0000950170-24-001971

Options or other derivatives

  • Director acquired 35,604 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
Derivatives
Tregoning Kathleen Director 2024-01-02 Grant or award · Stock Option (Right to Buy) +35,604 $1.12 $39,876 35,604 D
Loading xslF345X05/ownership.xml…